{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:50:13Z","timestamp":1792461013256,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/mca.0b013e3282f3420c","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T08:22:31Z","timestamp":1236241351000},"page":"105-110","source":"Crossref","is-referenced-by-count":39,"title":["Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina"],"prefix":"10.1097","volume":"19","author":[{"given":"Toshiaki","family":"Otsuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikao","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Kodani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kusama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Atarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210204","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1749-6632.1982.tb55218.x","article-title":"Role of coronary arterial spasm in sudden coronary ischemic death","volume":"382","author":"Maseri","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"R2-7-20210204","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/01.CIR.75.6.1110","article-title":"Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina","volume":"75","author":"Nakamura","year":"1987","journal-title":"Circulation"},{"key":"R3-7-20210204","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1536\/ihj.28.841","article-title":"Long-term prognosis of vasospastic angina without significant atherosclerotic coronary artery disease","volume":"28","author":"Egashira","year":"1987","journal-title":"Jpn Heart J"},{"key":"R4-7-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.78.1.1","article-title":"Long-term prognosis for patients with variant angina and influential factors","volume":"78","author":"Yasue","year":"1988","journal-title":"Circulation"},{"key":"R5-7-20210204","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.fjc.0000141473.29254.62","article-title":"Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers","volume":"44","author":"Ito","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"R6-7-20210204","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0002-9149(86)90200-6","article-title":"Late follow-up (41 to 102 months) of medically treated patients with coronary artery spasm and minor atherosclerotic coronary obstructions","volume":"57","author":"Freedman","year":"1986","journal-title":"Am J Cardiol"},{"key":"R7-7-20210204","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/01.CIR.76.5.990","article-title":"Long-term prognosis of patients with variant angina","volume":"76","author":"Walling","year":"1987","journal-title":"Circulation"},{"key":"R8-7-20210204","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/oxfordjournals.eurheartj.a014996","article-title":"Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients","volume":"17","author":"Bory","year":"1996","journal-title":"Eur Heart J"},{"key":"R9-7-20210204","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.63.4.844","article-title":"Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan","volume":"63","author":"Kimura","year":"1981","journal-title":"Circulation"},{"key":"R10-7-20210204","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.ATV.0000176193.83629.c8","article-title":"Rho-kinase is an important therapeutic target in cardiovascular medicine","volume":"25","author":"Shimokawa","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R11-7-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1253\/jcj.64.1","article-title":"Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models","volume":"64","author":"Shimokawa","year":"2000","journal-title":"Jpn Circ J"},{"key":"R12-7-20210204","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.fjc.0000134775.76636.3f","article-title":"Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery","volume":"44","author":"Inokuchi","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"R13-7-20210204","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/hc1002.105938","article-title":"Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina","volume":"105","author":"Masumoto","year":"2002","journal-title":"Circulation"},{"key":"R15-7-20210204","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.85.5.1899","article-title":"Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity","volume":"85","author":"Doucette","year":"1992","journal-title":"Circulation"},{"key":"R16-7-20210204","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.273.5272.245","article-title":"Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)","volume":"273","author":"Kimura","year":"1996","journal-title":"Science"},{"key":"R17-7-20210204","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.CIR.101.11.1319","article-title":"Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1\u03b2","volume":"101","author":"Kandabashi","year":"2000","journal-title":"Circulation"},{"key":"R18-7-20210204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1006076409185","article-title":"How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?","volume":"14","author":"Jost","year":"1998","journal-title":"Int J Card Imaging"},{"key":"R19-7-20210204","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.CIR.92.2.183","article-title":"Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo","volume":"92","author":"Kuga","year":"1995","journal-title":"Circulation"},{"key":"R20-7-20210204","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0735-1097(92)90181-L","article-title":"Endothelium-dependent dilator response to substance P in patients with coronary spastic angina","volume":"20","author":"Okumura","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"R21-7-20210204","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.CIR.94.3.266","article-title":"Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina","volume":"94","author":"Kugiyama","year":"1996","journal-title":"Circulation"},{"key":"R22-7-20210204","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/hrt.75.3.267","article-title":"Relation of basal coronary tone and vasospastic activity in patients with variant angina","volume":"75","author":"Ozaki","year":"1996","journal-title":"Heart"},{"key":"R23-7-20210204","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0735-1097(89)90100-9","article-title":"Significance of coronary artery tone in patients with vasospastic angina","volume":"14","author":"Hoshio","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"R24-7-20210204","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1253\/circj.66.58","article-title":"Tetrahydrobiopterin improves coronary endothelial function, but does not prevent coronary spasm in patients with vasospastic angina","volume":"66","author":"Fukuda","year":"2002","journal-title":"Circ J"},{"key":"R25-7-20210204","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/0735-1097(89)90382-3","article-title":"Spontaneous coronary artery spasm in variant angina is caused by a local hyper reactivity to a generalized constrictor stimulus","volume":"14","author":"Kaski","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"R26-7-20210204","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(96)00824-7","article-title":"Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina","volume":"79","author":"Kugiyama","year":"1997","journal-title":"Am J Cardiol"},{"key":"R27-7-20210204","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"R28-7-20210204","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1253\/circj.70.402","article-title":"Vasodilatory effect of subsequent administration of fasudil, a Rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris","volume":"70","author":"Otsuka","year":"2006","journal-title":"Circ J"},{"key":"R29-7-20210204","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.07.047","article-title":"Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial","volume":"46","author":"Vicari","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R30-7-20210204","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/hrt.2003.029470","article-title":"Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension","volume":"91","author":"Fukumoto","year":"2005","journal-title":"Heart"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0b013e3282f3420c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:43:12Z","timestamp":1786038192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019501-200803000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0b013e3282f3420c","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}